Breaking news Novartis’ Q3 EPS tumbles 41% to $0.73 Ottobre 25, 2022 Novartis AG revealed on Tuesday that its earnings per share (EPS) in the third trimester of fiscal 2022 slid as much as 41% on an annual basis to stand at $0.73. Additionally, the multinational pharm…
